$LP-127 Tacrolimus is effective treatment in patients with refractory lupus nephritis$

LP-127 Tacrolimus is effective treatment in patients with refractory lupus nephritis

Bibliographic Details
Main Authors:	Chang-Hee Suh, Ju-Yang Jung, Hyoun-Ah Kim, Ji-Won Kim
Format:	Article
Language:	English
Published:	BMJ Publishing Group 2023-07-01
Series:	Lupus Science and Medicine

Similar Items

LP-022 Preference and efficacy of zoledronate for the treatment of glucocorticoid-induced osteoporosis in patients with autoimmune disease including systemic lupus erythematosus
by: Chang-Hee Suh, et al.
Published: (2023-07-01)

LP-059 Association of seasonal vitamin D levels and disease activity in patients with systemic lupus erythematosus
by: Chang-Hee Suh, et al.
Published: (2023-07-01)

LP-009 Immunoglobulin gamma-3 subclass is a potential biomarker in seruma, saliva, and urine of patients with systemic lupus erythematosus
by: Sang-Won Lee, et al.
Published: (2023-07-01)

LP-082 Effects of rosuvastatin for the treatment in lupus-prone mice
by: Sang-Won Lee, et al.
Published: (2023-07-01)

PO.5.107 Real-world clinical response of tacrolimus treatment in patients with lupus nephritis
by: J Kim, et al.
Published: (2022-10-01)

POS-127 RENAL LYMPHANGIOGENESIS IN LUPUS NEPHRITIS
by: W. Li, et al.
Published: (2021-04-01)

LP-099 High genetic risk loads increase the risk of lupus nephritis in Koreans
by: Sang-Cheol Bae, et al.
Published: (2023-07-01)

Sex hormones affect the pathogenesis and clinical characteristics of systemic lupus erythematosus
by: Ji-Won Kim, et al.
Published: (2022-08-01)

Glycol chitosan-based tacrolimus-loaded nanomicelle therapy ameliorates lupus nephritis
by: Chang Seong Kim, et al.
Published: (2021-04-01)

LP-128 Relative efficacy and safety of tacrolimus, mycophenolate mofetil, and azathioprine as maintenance therapies for lupus nephritis: a network meta-analysis
by: Young Ho Lee, et al.
Published: (2023-07-01)

LSO-093 Gut microbiota analysis in Korean patients with systemic lupus erythematosus
by: Chang-Hee Suh, et al.
Published: (2023-07-01)

Rituximab in the treatment of refractory lupus nephritis with vasculitis
by: Huseyin Kadikoy, et al.
Published: (2012-01-01)

23 Refractory lupus nephritis
by: Sandra Navarra
Published: (2020-09-01)

LSO-044 Sphingolipids are potential diagnostic biomarkers for Korean patients with systemic lupus erythematosus
by: Chang-Hee Suh, et al.
Published: (2023-07-01)

A case of lupus nephritis treated with clarithromycin, tacrolimus, and glucocorticoids
by: Masashi Ohe
Published: (2016-09-01)

LP-135 High neutrophil-to-lymphocyte ratio is a risk factor for chronic kidney disease in patients with lupus nephritis
by: Hyemin Jeong, et al.
Published: (2023-07-01)

Telitacicept Treatment Refractory Lupus Nephritis: A Case Report
by: Sijia Li, et al.
Published: (2024-03-01)

Long-Term Results of Triple Immunosuppression With Tacrolimus Added to Mycophenolate and Corticosteroids in the Treatment of Lupus Nephritis
by: Desmond Y.H. Yap, et al.
Published: (2022-03-01)

Management of refractory lupus nephritis: challenges and solutions
by: Yo JH, et al.
Published: (2019-07-01)

S100A8 in Serum, Urine, and Saliva as a Potential Biomarker for Systemic Lupus Erythematosus
by: Ji-Won Kim, et al.
Published: (2022-04-01)

P28 TAC-TIC USE OF TACROLIMUS-BASED REGIMENS IN LUPUS NEPHRITIS
by: T. Kraaij, et al.
Published: (2016-11-01)

Treatment of refractory lupus nephritis using leflunomide: A prospective study
by: Shuo Zhang, et al.
Published: (2023-03-01)

LP-097 Degranulating PR3+ myeloid cells characterize proliferative lupus nephritis
by: Michelle Petri, et al.
Published: (2023-07-01)

LBO2 Long-term renal and cardiovascular risks of tacrolimus in lupus nephritis patients
by: Obbo W Bredewold, et al.
Published: (2024-03-01)

LP-066 Severe Systemic lupus erythematosus with manifestation of lupus nephritis and pericardial effusion: a case report
by: Arief Nurudhin, et al.
Published: (2023-07-01)

Increased Immunoglobulin Gamma-3 Chain C in the Serum, Saliva, and Urine of Patients with Systemic Lupus Erythematosus
by: Ju-Yang Jung, et al.
Published: (2023-04-01)

P90 Use of belimumab in patients with lupus nephritis refractory to standard treatment
by: Debasish Pyne, et al.
Published: (2024-03-01)

Experience using low doses of calcineurin inhibitors in the treatment of refractory lupus nephritis
by: César Augusto Restrepo Valencia, et al.
Published: (2014-10-01)

Addition of cyclosporine/tacrolimus for pediatric relapsed lupus nephritis during mycophenolate mofetil maintenance therapy
by: Youying Mao, et al.
Published: (2019-01-01)

LSO-016 Activated leukocyte cell adhesion molecule, hemopexin, and peroxiredoxin 6 as a potential urine biomarker for Korean patients with systemic lupus erythematosus
by: Sang-Won Lee, et al.
Published: (2023-07-01)

LP-126 The infectious complication in multitarget therapy of class V lupus nephritis: a case report
by: Anastasiia Shumilova, et al.
Published: (2023-07-01)

LP-098 Proteomic analysis of histological lesions in lupus nephritis identifies an inflammatory signature of fibrous crescents
by: Laurence S Magder, et al.
Published: (2023-07-01)

LP-185 Treatment of cutaneous lupus erythematosus with energy based devices
by: Jeong Eun Kim, et al.
Published: (2023-07-01)

Tacrolimus Protects Podocytes from Injury in Lupus Nephritis Partly by Stabilizing the Cytoskeleton and Inhibiting Podocyte Apoptosis.
by: Ruyi Liao, et al.
Published: (2015-01-01)

LP-124 Childhood-onset lupus nephritis: real world long-term outcome data from a single center
by: Jiwon Jung, et al.
Published: (2023-07-01)

LP-190 Successful treatment of rituximab and bortezomib in refractory systemic lupus erythematosus: a case report
by: Chen Chen, et al.
Published: (2023-07-01)

LP-181 Effect and safety profile of belimumab and tacrolimus combination therapy in thirty-three patients with systemic lupus erythematosus
by: Masato Okada
Published: (2023-07-01)

LP-085 Investigating the therapeutic potential of achatina fulica snail mucus on pristane-induced lupus nephritis in mice
by: Arief Nurudhin, et al.
Published: (2023-07-01)

Biomarkers Associated with Drugs for the Treatment of Lupus Nephritis
by: Huiyu Nie, et al.
Published: (2023-10-01)

Induction and Maintenance Treatment of Lupus Nephritis: A Comprehensive Review of Meta-Analyses
by: Jae Il Shin, et al.
Published: (2022-01-01)